What is the immuno-oncology market size in 2026?

The global immuno-oncology market is projected to reach US$66.2 billion in 2026.

What drives the immuno-oncology market?

Rising cancer incidence, expanding approvals of immunotherapies, advances in checkpoint inhibitors and cell therapies, and growing adoption of targeted and combination treatments drive market growth.

What is the growth rate for the immuno-oncology market?

The immuno-oncology market is expected to grow at a CAGR of 23.9% from 2026 to 2033.

What are the key market opportunities?

Key opportunities lie in next-generation cell therapies, personalized cancer vaccines, bispecific antibodies, biomarker-guided treatments, and combination therapies targeting treatment-resistant cancers.

Who are the key players in the immuno-oncology market?

Bristol Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd, and Merck & Co., Inc. are the leading players.

Table of Content - Immuno-Oncology Market Size, Share, and Growth Forecast, 2026

Executive Summary
1. Global Immuno-Oncology Market Snapshot, 2026and 2033
2. Market Opportunity Assessment, 2026– 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Specialty Clinics Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors – Relevance and Impact
Value Added Insights
1. Treatment Type Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Immuno-Oncology Market Outlook:
1. Key Highlights
  1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, 2025–2033
3. Global Immuno-Oncology Market Outlook: By Product Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Product Type,2020-2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2026– 2033
    1. Immune Cell Therapy (CAR-T)
    2. Monoclonal Antibodies
    3. Checkpoint Inhibitors
    4. Cytokines
    5. Cancer Vaccines
    6. Others
  4. Market Attractiveness Analysis: By Product Type
4. Global Immuno-Oncology Market Outlook: By Indication
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Indication,2020-2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2026– 2033
    1. Malignant Tumors
    2. Benign Tumors
  4. Market Attractiveness Analysis: Indication
Global Immuno-Oncology Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Region,2020-2025
3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026– 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Immuno-Oncology Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product Type
  3. By Indication
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2026– 2033
  1. Immune Cell Therapy (CAR-T)
  2. Monoclonal Antibodies
  3. Checkpoint Inhibitors
  4. Cytokines
  5. Cancer Vaccines
  6. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2026– 2033
  1. Malignant Tumors
  2. Benign Tumors
Europe Immuno-Oncology Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product Type
  3. By Indication
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2026– 2033
  1. Immune Cell Therapy (CAR-T)
  2. Monoclonal Antibodies
  3. Checkpoint Inhibitors
  4. Cytokines
  5. Cancer Vaccines
  6. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2026– 2033
  1. Malignant Tumors
  2. Benign Tumors
East Asia Immuno-Oncology Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product Type
  3. By Indication
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2026– 2033
  1. Immune Cell Therapy (CAR-T)
  2. Monoclonal Antibodies
  3. Checkpoint Inhibitors
  4. Cytokines
  5. Cancer Vaccines
  6. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2026– 2033
  1. Malignant Tumors
  2. Benign Tumors
South Asia & Oceania Immuno-Oncology Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product Type
  3. By Indication
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2026– 2033
  1. Immune Cell Therapy (CAR-T)
  2. Monoclonal Antibodies
  3. Checkpoint Inhibitors
  4. Cytokines
  5. Cancer Vaccines
  6. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2026– 2033
  1. Malignant Tumors
  2. Benign Tumors
Latin America Immuno-Oncology Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product Type
  3. By Indication
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2026– 2033
  1. Immune Cell Therapy (CAR-T)
  2. Monoclonal Antibodies
  3. Checkpoint Inhibitors
  4. Cytokines
  5. Cancer Vaccines
  6. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2026– 2033
  1. Malignant Tumors
  2. Benign Tumors
Middle East & Africa Immuno-Oncology Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product Type
  3. By Indication
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2026– 2033
  1. Immune Cell Therapy (CAR-T)
  2. Monoclonal Antibodies
  3. Checkpoint Inhibitors
  4. Cytokines
  5. Cancer Vaccines
  6. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2026– 2033
  1. Malignant Tumors
  2. Benign Tumors
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping by Market
  2. Competition Dashboard
3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
  1. Bristol Myers Squibb Company
    1. Overview
    2. Segments and Treatment Types
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Novartis AG
  3. F. Hoffmann-LA Roche Ltd.
  4. Merck & Co., Inc.
  5. GSK Plc.
  6. Eli Lilly and Company
  7. Fresenius Kabi AG
  8. Pfizer Inc.
  9. AbbVie Inc.
  10. Genentech Inc.
  11. Sanofi
  12. AstraZeneca
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Immuno-Oncology Market Size, Share, and Growth Forecast, 2026 – 2033

Immuno-Oncology Market by Product Type (Immune Cell Therapy (CAR-T), Monoclonal Antibodies, Checkpoint Inhibitors, Cytokines, Cancer Vaccines), Indication (Malignant Tumors, Benign Tumors), and Regional Analysis for 2026 – 2033

Quick Links

Our Partners

Secure Payments Through